4th European Seminars in Virology on Oncogenic and Oncolytic Viruses, in Bertinoro (Bologna), Italy

The 4th European Seminars in Virology (EuSeV), which was focused on oncogenic and oncolytic viruses, was held in Bertinoro (Bologna), Italy, from June 10 to 12, 2016. This article summarizes the plenary lectures and aims to illustrate the main topics discussed at 4th EuSeV, which brought together kn...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular physiology 2017-10, Vol.232 (10), p.2641-2648
Hauptverfasser: Reale, Alberto, Messa, Lorenzo, Vitiello, Adriana, Loregian, Arianna, Palù, Giorgio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The 4th European Seminars in Virology (EuSeV), which was focused on oncogenic and oncolytic viruses, was held in Bertinoro (Bologna), Italy, from June 10 to 12, 2016. This article summarizes the plenary lectures and aims to illustrate the main topics discussed at 4th EuSeV, which brought together knowledge and expertise in the field of oncogenic and oncolytic viruses from all over the world. The meeting was divided in two parts, “Mechanisms of Viral Oncogenesis” and “Viral Oncolysis and Immunotherapy,” which were both focused on dissecting the complex and multi‐factorial interplay between cancer and human viruses and on exploring new anti‐cancer strategies. J. Cell. Physiol. 232: 2641–2648, 2017. © 2016 Wiley Periodicals, Inc. The 4th European Seminars in Virology (EuSeV), which was focused on oncogenic and oncolytic viruses, was held in Bertinoro (Bologna), Italy, from June 10 to 12, 2016. This article summarizes the plenary lectures and aims to illustrate the main topics discussed at 4th EuSeV, which brought together knowledge and expertise in the field of oncogenic and oncolytic viruses from all over the world. The meeting was divided in two parts, “Mechanisms of Viral Oncogenesis” and “Viral Oncolysis and Immunotherapy,” which were both focused on dissecting the complex and multi‐factorial interplay between cancer and human viruses and on exploring new anti‐cancer strategies.
ISSN:0021-9541
1097-4652
DOI:10.1002/jcp.25692